Prescription Drug Abuse Screening & Pain Management Plan Training Simulation

描述（由申请人提供）：处方药滥用是一个日益关注的几个原因。获得多个处方和早期再配药的做法对使用处方药的患者构成了许多健康风险;由于多个处方或早期再配药没有受到密切监测，有时需要初级保健医生适当筛查潜在的处方药滥用和成瘾迹象。初级保健机构的临床医生应具备识别潜在滥用迹象的知识，以及处理被认为对处方药上瘾或滥用处方药的患者的必要步骤。这种互动可能很困难，因为许多患者要么不知道，要么回避他们的成瘾或滥用。提供模拟培训，帮助临床医生更好地筛选潜在的处方药滥用患者，并确定治疗方法，以帮助这些高风险患者处理他们的慢性疼痛将是非常有效的。对于第二阶段的应用，SIMmersion LLC与威斯康星州大学的Michael Fleming博士合作，建议开发和评估一个功能齐全的交互式模拟，以培训初级保健环境中的临床医生如何筛选处方药滥用和应用疼痛管理计划。拟议的培训模拟将允许医生和其他初级保健从业人员在患有慢性疼痛的患者中实践处方阿片类药物滥用的检测和管理。理想的结果是，临床医生对这些技能变得更加熟练和舒适，因此更有可能将其作为所有患者实践的常规部分，从而减少因滥用处方药而受到伤害的人数。为了评估模拟训练系统的有效性，弗莱明博士和他的研究小组将进行一项教育试验。将100名学生和从业人员随机分配到处方药滥用和误用的常规教育（n=50）或SIMmersion培训计划（n=50）。受试者将完成基线和6个月后的知识和临床行为测量。这些措施将包括一个知识纸和纸测试和标准化的病人。该研究将在UW健康科学临床教学和评估中心进行。使用SIMmersion技术的模拟患者程序预计将大大提高我们培训医疗专业人员的人类处理和交互技能的能力。我们预计SBIR赠款的最终结果将包括提高医疗保健专业人员在处方药筛选和疼痛管理计划应用方面的技能，以及改善使用处方药管理慢性疼痛的患者的治疗效果。 公共卫生相关性：创新和经济的技术，帮助初级保健临床医生获得能力，筛选处方药滥用和慢性疼痛管理的患者，可以帮助提高频率和有效性，筛选潜在的滥用。在初级保健环境中筛查处方药滥用患者并实施治疗管理计划可能有助于更快地发现滥用情况，并导致改变生活的干预措施，这可能会减少处方药和其他药物滥用和成瘾的负面影响。

DESCRIPTION (provided by applicant): Prescription drug abuse is a growing concern for several reasons. The practice of obtaining multiple prescriptions and early refills poses a number of health risks for patients who use prescription drugs; because multiple prescriptions or early refills are not closely monitored, it is sometimes up to the primary care physician to properly screen for signs of potential prescription drug abuse and addiction. Clinicians in primary care settings should be equipped with the knowledge to recognize the signs of potential abuse, as well as the steps necessary to address patients who are deemed to be addicted to, or abusing, prescription drugs. The interaction can be difficult, because many patients are either unaware of or evasive about their addiction or abuse. Providing simulation training to help prepare clinicians to better screen patients for potential prescription drug abuse and to identify treatment methods to help these high-risk patients deal with their chronic pain would be very effective. For the Phase II application, SIMmersion LLC, in cooperation with Dr. Michael Fleming of the University of Wisconsin, proposes to develop and evaluate a full-featured interactive simulation to train clinicians in primary care settings how to screen for prescription drug misuse and apply pain management plans. The proposed training simulation will allow physicians and other primary healthcare practitioners to practice the detection and management of prescription opioid misuse in patients suffering from chronic pain. The ideal outcome would be that clinicians become more proficient and comfortable with these skills, and therefore more likely to use them as a routine part of their practice with all patients, thereby reducing the number of people being harmed by the misuse of prescription drugs. To evaluate the efficacy of the simulation training system, Dr. Fleming and his research team will conduct an educational trial. One hundred students and practitioners will be randomly assigned to usual education on prescription drug abuse and misuse (n=50) or to the SIMmersion training program (n=50). Subjects will complete baseline and 6-month post-measures of knowledge and clinical behavior. The measures will include a knowledge pencil-and-paper test and standardized patients. The research will be conducted at the UW Health Sciences Clinical Teaching and Assessment Center. The simulated patient program, using the SIMmersion technology, is expected to significantly advance our ability to train medical professionals in human processing and interaction skills. We expect the end result of the SBIR grant will include improved skills among healthcare professionals in prescription drug screening and application of pain management plans, as well as improved patient outcomes for those who use prescription drugs to manage chronic pain. PUBLIC HEALTH RELEVANCE: Innovative and economical technologies that assist primary care clinicians in acquiring competence in screening patients for prescription drug abuse and chronic pain management could help increase the frequency and efficacy of screening for potential abuse. Screening patients for prescription drug abuse in primary care settings and implementing treatment management plans may help identify abuse sooner and lead to life-changing interventions, which could reduce the negative impact of prescription and other drug abuse and addiction.